Technology Licensing

Creative monetisation of de-prioritised IP is the next frontier for Big Pharma strategists

Despite their commitments to specialisation, large life sciences companies must not neglect the value of sidelined patents, know-how and other intangible assets

Creative monetisation of de-prioritised IP is the next frontier for Big Pharma strategists
Negotiating patent licensing agreements during a pandemic
2 Mar 2021

Negotiating patent licensing agreements during a pandemic

Co-published - Although some major deals in the semiconductor space have been concluded over the last year, respondents to a survey on virtual negotiations see major difficulties in online discussions

Xperi pushes plans for patent business separation into next year
26 Feb 2021

Xperi pushes plans for patent business separation into next year

Company puts Comcast litigation firmly in rear-view mirror while announcing $635.6 million in licensing revenue for 2020


View all
25 Feb 2021

IEEE opens review of controversial patent policy

Standards body calls for “removal or revision” of factors relating to royalty calculations and injunctive relief Read more

25 Feb 2021

IV taps local partners to roll out licensing programme aimed at Chinese SMEs

Intellectual Ventures is just the latest big IP market player to set its sights on China, with a new programme COO Arvin Patel says is the first of its kind Read more

24 Feb 2021

Ericsson, Samsung spar over venue and FRAND in Wuhan court hearing

Arguing for reversal of an anti-suit injunction passed last December, Swedish company suggests “broad, severe and global” ruling could amount to forced tech transfer Read more

23 Feb 2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The launch of Centessa is the latest development in a trend that has big implications for the monetisation of unpartnered or deprioritised IP-backed pharma assets Read more


View all
22 Dec 2020

The keys to effective IP monetisation

Patent licensing is as much an art as it is a science, explain some of those featured in the new IAM Strategy 300 Global Leaders guide Read more

19 Dec 2020

Those who adopt a hold-out strategy in SEP FRAND licensing should face the prospect of a market red card

Football shows how to deal with the long delays in licensing negotiations caused by those doing all they can to avoid paying a fair royalty, argues InterDigital’s Eeva Hakoranta Read more

14 Dec 2020

The last 12 months have been good for patent owners, say global IP leaders

Exclusive Panels Report for IAM focuses on key issues, including: portfolio management, litigation, monetisation, the regulatory environment and strategic priorities Read more

28 Nov 2020

The EU has the chance to seize global patent leadership

Europe has never been in a better position to set rules the rest of the world must follow Read more


View all
22 Feb 2021

Huawei projects big smartphone production cut for year ahead and that matters for licensors

Company insists it won’t sell off handset business entirely, but its procurement plans suggest we’ll see further fragmentation in market at a time when there are already concerns around royalty streams for patent owners Read more

20 Feb 2021

Why the US must now take the lead on SEP FRAND

Being a rule taker does not sit well with American interests nor with those of the wider global patent community. It is time for a change of approach Read more

19 Feb 2021

InterDigital reaps benefits of Huawei deal with jump in 2020 revenues; CEO Merritt eyes M&A opportunities

The patent licensor entered 2021 in a strong cash position but litigation costs ticked up thanks to Xiaomi and Lenovo fights Read more

19 Feb 2021

Dialog’s patents will boost Renesas’ fast growing licensing business

The purchase of the UK chipmaker will contribute to the monetisation programme’s potential, particularly within circuit technologies Read more


View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more